Cargando…

334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure

BACKGROUND: Patients with spinal cord injuries frequently develop sacral osteomyelitis. Optimal treatment often involves intravenous antibiotics and skin flap closure of the ulcer; however, best practices for the duration of antibiotic therapy pre- and post-procedure are unknown. METHODS: This was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Frye, Emily, Linneman, Travis W, Moenster, Ryan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776350/
http://dx.doi.org/10.1093/ofid/ofaa439.530
_version_ 1783630661961121792
author Frye, Emily
Linneman, Travis W
Moenster, Ryan P
author_facet Frye, Emily
Linneman, Travis W
Moenster, Ryan P
author_sort Frye, Emily
collection PubMed
description BACKGROUND: Patients with spinal cord injuries frequently develop sacral osteomyelitis. Optimal treatment often involves intravenous antibiotics and skin flap closure of the ulcer; however, best practices for the duration of antibiotic therapy pre- and post-procedure are unknown. METHODS: This was a retrospective, cohort study of spinal cord injury patients at the VA St. Louis undergoing a skin flap procedure from 1 October 2014 to 31 March 2019. Patients aged 18 to 89 years with a documented spinal cord injury and receiving treatment for sacral osteomyelitis with antibiotics and skin flap placement were considered for inclusion. The primary outcome was to determine if there was a difference in antibiotic treatment duration, both pre-procedure and post-procedure, between those that failed combination therapy and those patients for which the treatment was successful. Treatment failure was defined as documentation of no resolution of sacral osteomyelitis after treatment, re-initiation of antibiotics for sacral osteomyelitis of the same area, documented flap break-down, or an unplanned flap-related procedure within 1 year of completion of antibiotic therapy. RESULTS: Twelve patients were identified for inclusion. Baseline characteristics were similar between groups; 5/8 patients successfully treated received vancomycin, compared to 4/4 patients that failed therapy. Overall, 75% (8/12) had a successful treatment outcome at 12 months. In qualifying patients, average days of pre-procedure and post-procedure antibiotics were similar between patients who achieved success and those who failed (45.5 vs. 44.3 days pre-procedure, respectively (p >0.05) and 39 vs. 43 days post-procedure (p >0.05), respectively). When evaluated by weeks of therapy, no statistically significant differences were noted in treatment success rates between those treated for less than 6 weeks versus those treated for longer (66.6% [2/3] vs. 63.6% [6/9], p >0.05). CONCLUSION: No difference in pre- or post-flap procedure antibiotic duration was observed in patients who failed therapy compared to those who were successfully treated. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776350
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77763502021-01-07 334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure Frye, Emily Linneman, Travis W Moenster, Ryan P Open Forum Infect Dis Poster Abstracts BACKGROUND: Patients with spinal cord injuries frequently develop sacral osteomyelitis. Optimal treatment often involves intravenous antibiotics and skin flap closure of the ulcer; however, best practices for the duration of antibiotic therapy pre- and post-procedure are unknown. METHODS: This was a retrospective, cohort study of spinal cord injury patients at the VA St. Louis undergoing a skin flap procedure from 1 October 2014 to 31 March 2019. Patients aged 18 to 89 years with a documented spinal cord injury and receiving treatment for sacral osteomyelitis with antibiotics and skin flap placement were considered for inclusion. The primary outcome was to determine if there was a difference in antibiotic treatment duration, both pre-procedure and post-procedure, between those that failed combination therapy and those patients for which the treatment was successful. Treatment failure was defined as documentation of no resolution of sacral osteomyelitis after treatment, re-initiation of antibiotics for sacral osteomyelitis of the same area, documented flap break-down, or an unplanned flap-related procedure within 1 year of completion of antibiotic therapy. RESULTS: Twelve patients were identified for inclusion. Baseline characteristics were similar between groups; 5/8 patients successfully treated received vancomycin, compared to 4/4 patients that failed therapy. Overall, 75% (8/12) had a successful treatment outcome at 12 months. In qualifying patients, average days of pre-procedure and post-procedure antibiotics were similar between patients who achieved success and those who failed (45.5 vs. 44.3 days pre-procedure, respectively (p >0.05) and 39 vs. 43 days post-procedure (p >0.05), respectively). When evaluated by weeks of therapy, no statistically significant differences were noted in treatment success rates between those treated for less than 6 weeks versus those treated for longer (66.6% [2/3] vs. 63.6% [6/9], p >0.05). CONCLUSION: No difference in pre- or post-flap procedure antibiotic duration was observed in patients who failed therapy compared to those who were successfully treated. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776350/ http://dx.doi.org/10.1093/ofid/ofaa439.530 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Frye, Emily
Linneman, Travis W
Moenster, Ryan P
334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
title 334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
title_full 334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
title_fullStr 334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
title_full_unstemmed 334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
title_short 334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
title_sort 334. treatment duration of antibiotics for sacral osteomyelitis after skin flap procedure
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776350/
http://dx.doi.org/10.1093/ofid/ofaa439.530
work_keys_str_mv AT fryeemily 334treatmentdurationofantibioticsforsacralosteomyelitisafterskinflapprocedure
AT linnemantravisw 334treatmentdurationofantibioticsforsacralosteomyelitisafterskinflapprocedure
AT moensterryanp 334treatmentdurationofantibioticsforsacralosteomyelitisafterskinflapprocedure